Previously, Evans-Molina et al. (34) demonstrated that treatment of mouse models of diabetes and obesity with the PPARγ agonist pioglitazone improved glycemia with enhanced expression of Pdx1 and SetD7 proteins. Here, SETD7 is linked to obesity disorder.